| Autor: |
Maruyama Y; Department of Otorhinolaryngology Head and neck surgery, Showa University, School of Medicine., Hirano K; Department of Otorhinolaryngology Head and neck surgery, Showa University, School of Medicine., Sekino E; Department of Otorhinolaryngology Head and neck surgery, Kanto Rosai Hospital., Kamimura S; Department of Otorhinolaryngology, Showa University, Fujigaoka Hospital., Narikawa Y; Department of Otorhinolaryngology Head and neck surgery, Kanto Rosai Hospital., Suzaki I; Department of Otorhinolaryngology Head and neck surgery, Showa University, School of Medicine., Shimane T; Department of Otorhinolaryngology Head and neck surgery, Showa University, School of Medicine. |
| Abstrakt: |
Sublingual immunotherapy is a widely used treatment, and serious adverse reactions such as anaphylaxis are rare. We report two cases of laryngeal edema as adverse reactions to sublingual immunotherapy, which could be continued due to a change in the administration method. Case 1 presents a 15-year-old male suspected to have had anaphylaxis due to the dust at the age of 6 years. He started treatment with Miticure ® and developed laryngeal edema 30 minutes after taking the 10000JAU dose on the 10th day. laryngeal edema was treated with intravenous infusion. Case 2 presents a 48-year-old woman. She started treatment with Cidacure ® and developed respiratory distress and laryngeal edema 1 hour after taking the 5000JAU dose on the 5th day. she had resolved mildly without therapeutic intervention. In both cases, the patients were switched to sublingual spitting, resumed with the initial dose cautiously, and were able to continue. Sublingual immunotherapy is a safe treatment, but sudden adverse reactions may occur. Laryngeal symptoms may be treated by changing to the sublingual spitting method, but laryngeal findings should be examined, and the dosage should be carefully increased. |
